Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome.

CONTEXT The polycystic ovary syndrome (PCOS) is frequently associated with visceral obesity, suggesting that omental adipose tissue might play an important role in the pathogenesis of the syndrome. OBJECTIVE The objective was to study the expression profiles of omental fat biopsy samples obtained from morbidly obese women with or without PCOS at the time of bariatric surgery. DESIGN This was a case-control study. SETTINGS We conducted the study in an academic hospital. PATIENTS Eight PCOS patients and seven nonhyperandrogenic women submitted to bariatric surgery because of morbid obesity. INTERVENTIONS Biopsy samples of omental fat were obtained during bariatric surgery. MAIN OUTCOME MEASURE The main outcome measure was high-density oligonucleotide arrays. RESULTS After statistical analysis, we identified changes in the expression patterns of 63 genes between PCOS and control samples. Gene classification was assessed through data mining of Gene Ontology annotations and cluster analysis of dysregulated genes between both groups. These methods highlighted abnormal expression of genes encoding certain components of several biological pathways related to insulin signaling and Wnt signaling, oxidative stress, inflammation, immune function, and lipid metabolism, as well as other genes previously related to PCOS or to the metabolic syndrome. CONCLUSION The differences in the gene expression profiles in visceral adipose tissue of PCOS patients compared with nonhyperandrogenic women involve multiple genes related to several biological pathways, suggesting that the involvement of abdominal obesity in the pathogenesis of PCOS is more ample than previously thought and is not restricted to the induction of insulin resistance.

[1]  J. L. San Millán,et al.  Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. , 2004, The Journal of clinical endocrinology and metabolism.

[2]  J. Kirwan,et al.  Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. , 2006, The Journal of clinical endocrinology and metabolism.

[3]  Joaquín Dopazo,et al.  New Challenges in Gene Expression Data Analysis and the Extended GEPAS , 2004, Spanish Bioinformatics Conference.

[4]  H. Escobar-Morreale,et al.  Circulating leptin concentrations in women with hirsutism. , 1997, Fertility and sterility.

[5]  J. Youngren,et al.  Role of PC‐1 in The Etiology of Insulin Resistance , 1999, Annals of the New York Academy of Sciences.

[6]  J. L. San Millán,et al.  Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study. , 2006, Human reproduction.

[7]  Shiriki K. Kumanyika,et al.  Gastrointestinal surgery for severe obesity , 1991 .

[8]  D. Dunger,et al.  Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation. , 2002, The Journal of clinical endocrinology and metabolism.

[9]  J. L. San Millán,et al.  The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. , 2005, Endocrine reviews.

[10]  I. Goldfine,et al.  Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit. , 2000, Diabetes.

[11]  J. Fernández-Real,et al.  Insulin resistance and chronic cardiovascular inflammatory syndrome. , 2003, Endocrine reviews.

[12]  Purvesh Khatri,et al.  Onto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate , 2003, Nucleic Acids Res..

[13]  M. Miyazaki,et al.  Stearoyl-CoA desaturase 1 deficiency increases insulin signaling and glycogen accumulation in brown adipose tissue. , 2005, American journal of physiology. Endocrinology and metabolism.

[14]  U. Pagotto,et al.  Obesity and the polycystic ovary syndrome , 2002, International Journal of Obesity.

[15]  M. Urbanek,et al.  The Molecular Phenotype of Polycystic Ovary Syndrome (PCOS) Theca Cells and New Candidate PCOS Genes Defined by Microarray Analysis* , 2003, Journal of Biological Chemistry.

[16]  Joaquín Dopazo,et al.  BABELOMICS: a suite of web tools for functional annotation and analysis of groups of genes in high-throughput experiments , 2005, Nucleic Acids Res..

[17]  M. Kim,et al.  Hirsutism: implications, etiology, and management. , 1981, American journal of obstetrics and gynecology.

[18]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[19]  J. Pessin,et al.  Lipid Raft targeting of the TC10 amino terminal domain is responsible for disruption of adipocyte cortical actin. , 2003, Molecular biology of the cell.

[20]  A. Vermeulen,et al.  A critical evaluation of simple methods for the estimation of free testosterone in serum. , 1999, The Journal of clinical endocrinology and metabolism.

[21]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  L. Ibáñez,et al.  Premature adrenarche--normal variant or forerunner of adult disease? , 2000, Endocrine reviews.

[23]  Y. Matsuzawa,et al.  Increased insulin sensitivity and hypoglycaemia in mice lacking the p85α subunit of phosphoinositide 3–kinase , 1999, Nature Genetics.

[24]  M. Katoh,et al.  Human FOX gene family (Review). , 2004, International journal of oncology.

[25]  S. Franks,et al.  Polycystic ovary syndrome. , 1995, Archives of disease in childhood.

[26]  A. Murdoch,et al.  Tissue insulin sensitivity and body weight in polycystic ovary syndrome , 2001, Clinical endocrinology.

[27]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[28]  B. Walker,et al.  Genetic variation in 11β-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome , 2006 .

[29]  B. Fauser,et al.  Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients. , 2004, Molecular endocrinology.

[30]  Jeremy W Tomlinson,et al.  11 (cid:1) -Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response , 2004 .

[31]  M. Laakso,et al.  The 121Q allele of the plasma cell membrane glycoprotein 1 gene predisposes to polycystic ovary syndrome. , 2004, Fertility and sterility.

[32]  T. Werner,et al.  MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. , 1995, Nucleic acids research.

[33]  M. Berlan,et al.  Increased lipolysis in adipose tissue and lipid mobilization to natriuretic peptides during low-calorie diet in obese women , 2002, International Journal of Obesity.

[34]  Joseph L Evans,et al.  Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators. , 2002, The Journal of clinical endocrinology and metabolism.

[35]  G. Reaven,et al.  Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes , 1999, Diabetologia.

[36]  A. Goumenou,et al.  The role of leptin in fertility. , 2003, European journal of obstetrics, gynecology, and reproductive biology.

[37]  E. Bruckert,et al.  Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. , 2002, The Journal of clinical endocrinology and metabolism.

[38]  Ricardo Azziz,et al.  0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(6):2745–2749 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-032046 The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected , 2022 .

[39]  Dolian Gg,et al.  Diagnostic criteria for polycystic ovary syndrome , 1989 .

[40]  D. Leroith,et al.  Serine Phosphorylation Proximal to Its Phosphotyrosine Binding Domain Inhibits Insulin Receptor Substrate 1 Function and Promotes Insulin Resistance , 2004, Molecular and Cellular Biology.

[41]  A. Dunaif,et al.  Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. , 1995, The Journal of clinical investigation.

[42]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[43]  Benjamin Glaser,et al.  A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4 alpha gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an ashkenazi jewish population. , 2004, Diabetes.

[44]  P. Arner,et al.  A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance. , 2002, Diabetes.

[45]  J. Vuoristo,et al.  The partial female to male sex reversal in Wnt-4-deficient females involves induced expression of testosterone biosynthetic genes and testosterone production, and depends on androgen action. , 2005, Endocrinology.

[46]  N. Hoggard,et al.  Leptin: fundamental aspects , 1999, International Journal of Obesity.

[47]  J. Settleman,et al.  The PRK2 kinase is a potential effector target of both Rho and Rac GTPases and regulates actin cytoskeletal organization , 1997, Molecular and cellular biology.

[48]  G. Hotamisligil The role of TNFα and TNF receptors in obesity and insulin resistance , 1999 .

[49]  D. Abbott,et al.  Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? , 2005, Human reproduction update.

[50]  W. H. Hall,et al.  Gastrointestinal Surgery for Severe Obesity. , 1991, Obesity surgery.

[51]  J. L. San Millán,et al.  A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11beta-hydroxysteroid dehydrogenase type 1 gene 83557insA polymorphisms in the polycystic ovary syndrome. , 2005, The Journal of clinical endocrinology and metabolism.

[52]  P. Björntorp,et al.  Imprinting of female offspring with testosterone results in insulin resistance and changes in body fat distribution at adult age in rats. , 1998, The Journal of clinical investigation.

[53]  J. L. San Millán,et al.  Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. , 2006, Archives of internal medicine.

[54]  M. Stoffel,et al.  Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes , 2004, Nature.

[55]  M. Harma,et al.  Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. , 2001, Clinical biochemistry.

[56]  J. Ofrecio,et al.  Increased p85/55/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skeletal muscle. , 2005, Diabetes.

[57]  D. Cooke,et al.  Olf-1/Early B Cell Factor Is a Regulator ofglut4 Gene Expression in 3T3-L1 Adipocytes* , 2002, The Journal of Biological Chemistry.

[58]  B. Maddux,et al.  Membrane Glycoprotein PC1 Inhibition of Insulin Receptor Function Occurs Via Direct Interaction With the Receptor-Subunit , 1999 .

[59]  J. Olefsky,et al.  Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity. , 1997, The Journal of clinical endocrinology and metabolism.